A Clinical Study on the Combined Magnetic and Oxygen Treatment for Bell's Palsy
- Sponsor
- Wenzhou Medical University
- Study ID
- NCT01686464
- Status
- Completed
Conditions
- Bell's Palsy
Eligibility Criteria
- Sex
- ALL
- Age
- 10 Years - 74 Years
- Healthy Volunteers
- Not accepted
Interventions
- prednisone and valacyclovir treatments — DRUGpatients were administered prednisone as a single dose of 40 mg daily for 5 days; the dose will then be reduced by 10 mg per 5 day, with a total treatment time of 20 days.while taking valacyclovir 400 mg in three doses daily for 10 days.
- Magnetic and Oxygen Treatment — DEVICEMOMC treatment was given as daily 20 min section for 10 days with 2\~3 days of intermission between. Oxygen therapy was given simultaneously at a flow rate of 2\~3.0 L / min for the same duration during all acupuncture sections.
Study Details
The aim of this clinic trial is to testify the efficacy of using new and noninvasive therapy, called simultaneous "Magnetic and Oxygen Treatment along Meridians and Collaterals" (MOMC), to treat Bell's Palsy.
Key Dates
- Start date
- Jun 30, 1998
- Status verified
- Sep 2012
- Primary completion
- Jan 31, 2005
- Completion
- Jan 31, 2005
Study Design
- Enrollment
- 882 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Magnetic - OxygenMagnetic and Oxygen Treatment for Bell's Palsy
- Active Comparator: prednisone - valacyclovirprednisone and valacyclovir treatments for bell palsy
Primary Outcome Measure
House-Brackmann scale [ Time Frame: the 20th day of completion of the treatment ]
Related Studies
- Safety and Effectiveness of the BlinkER System in Participants With Facial Nerve PalsyNot Yet Recruiting · Neurotrigger Ltd · Deerfield Beach, Florida